Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Dietary Intake of Tryptophan and Metformin Response

Early Phase 1

Completed

Conditions: Metformin Response
Fasting Glucose
Metformin Concentration
Tryptophan Concentration
Diet Tolerability

Interventions: Drug: Metformin
Other: Low tryptophan diet
Other: High tryptophan diet

First Posted Date: 2014-07-09

Last Posted Date: 2016-03-16

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT02184832

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Closed-Loop Glucagon Administration For Hypoglycemia Treatment

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Device: Glucagon-only Bionic Pancreas

First Posted Date: 2014-07-03

Last Posted Date: 2019-01-10

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 31

Registration Number: NCT02181127

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Denosumab and Teriparatide Study (DATA-HD and DATA-EX)

Phase 4

Completed

Conditions: Postmenopausal Osteoporosis

Interventions: Drug: denosumab
Drug: teriparatide
Drug: Zoledronic acid

First Posted Date: 2014-06-27

Last Posted Date: 2021-02-09

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 76

Registration Number: NCT02176382

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Improving Faculty's Ability to Speak Up to Others in the Operating Room

Not Applicable

Completed

Conditions: Faculty, Medical

Interventions: Other: Educational Workshop on Speaking-Up
Other: Unrelated Education (CPR)

First Posted Date: 2014-06-23

Last Posted Date: 2014-06-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 310

Registration Number: NCT02170818

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis

Phase 4

Completed

Conditions: Microscopic Polyangiitis
Granulomatosis With Polyangiitis

Interventions: Drug: Glucocorticoids
Drug: Rituximab

First Posted Date: 2014-06-23

Last Posted Date: 2021-06-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT02169219

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia

Phase 2

Completed

Conditions: Schizophrenia

Interventions: Drug: sodium nitroprusside
Other: Placebo

First Posted Date: 2014-06-17

Last Posted Date: 2018-10-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT02164981

Locations: 🇺🇸
New York University Langone Medical Center/Bellevue Hospital, New York, New York, United States
🇺🇸
Zucker Hillside Hospital, Glen Oaks, New York, United States
🇺🇸
University of Massachusetts Medical School, Worcester, Massachusetts, United States

and more 1 locations

A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography

Phase 4

Withdrawn

Conditions: Contrast Media Allergy

Interventions: Drug: Gadolinium

First Posted Date: 2014-06-13

Last Posted Date: 2021-05-04

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT02163005

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Effects of Botox in Obstructed Defecation Syndrome

Phase 2

Terminated

Conditions: Obstructed Defecation Syndrome (ODS)

Interventions: Drug: Normal Saline
Drug: Botulinum Toxin-A

First Posted Date: 2014-06-10

Last Posted Date: 2020-05-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1

Registration Number: NCT02160288

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer

Not Applicable

Completed

Conditions: Adherence to Medication Regime
Cancer

Interventions: Other: Mobile Application Intervention

First Posted Date: 2014-06-06

Last Posted Date: 2018-11-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 212

Registration Number: NCT02157519

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital At Emerson Hospital-Bethke, Concord, Massachusetts, United States
🇺🇸
Massachusetts General Hospital/North Shore Cancer Center, Boston, Massachusetts, United States

Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

Not Applicable

Completed

Conditions: Multiple Myeloma
Amyloidosis

Interventions: Drug: Tacrolimus
Drug: Equine Anti-thymocyte globulin
Procedure: Kidney transplant from a related donor
Drug: Bone marrow transplant from a related donor
Radiation: Total body irradiation 400 centigray (200 cGy X 2)

First Posted Date: 2014-06-06

Last Posted Date: 2022-12-13

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 2

Registration Number: NCT02158052

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy